p53 gene therapy in a rat model of hepatocellular carcinoma: Intra- arterial delivery of a recombinant adenovirus

Clinical Cancer Research

Volumn 4, Issue 7, 1998, Pages 1649-1659

  Anderson, Scott C ^a   Johnson, Duane E ^a   Harris, Matthew P ^a,b   Engler, Heidrun ^a   Hancock, Wendy ^a   Huang, Whei Mei ^a   Wills, Ken N ^a   Gregory, Richard J ^a,c   Sutjipto, Suganto ^a   Wen, Shu Fen ^a   Lofgren, Sam ^a   Shepard, H Michael ^a   Maneval, Daniel C ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTERY CATHETERIZATION; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HEPATIC ARTERY; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; RAT; SEQUENCE ANALYSIS; TRANSGENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; DEFECTIVE VIRUSES; FEMALE; GENE EXPRESSION; GENE THERAPY; GENES, P53; GENETIC VECTORS; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; LIVER NEOPLASMS, EXPERIMENTAL; NEOPLASM PROTEINS; RATS; TRANSGENES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 14444267312     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Ravoet, C., Bleiberg, H., and Gerard, B. Non-surgical treatment of hepatocellular carcinoma. J. Surg. Oncol., 3 (Suppl.): 104-111, 1993.
2. Venook, A. P. Treatments of hepatocellular carcinoma: too many options? J. Clin. Oncol., 12: 1323-1334, 1994.
3. Breedis, C., and Young, G. The blood supply of neoplasms in the liver. Am. J. Pathol., 30: 969-985, 1954.
4. Ravikumar, T. S., Pizzorno, G., Bodden, W., Marsh, J., Strair, R., Pollack, J., Hendler, R., Hanna, J., and D'Andrea, E. Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors. J. Clin. Oncol., 12: 2723-2736, 1994.
5. Atiq, O. T., Kemeny, N., Niedzwiecki, D., and Botet, J. Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump. Cancer (Phila.), 69: 920-924, 1992.
6. Yodono, H., Sasaki, T., Tarusawa, K., Midorikawa, H., Saito, Y., and Takekawa, S. D. Arterial infusion chemotherapy for advanced hepatocellular carcinoma using EPF and EAR therapies. Cancer Chemother. Pharmacol., 31: S89-S92, 1992.
7. Doci, R., Bignami, P., Bozzetti, F., Giuliano, B., Audisio, R., Colombo, M., and Gennari, L. Intrahepatic chemotherapy for unresectable hepatocellular carcinoma. Cancer (Phila.), 61: 1983-1987, 1988.
8. Stagg, R. J., Lewis, B. J., Friedman, M. A., Ignoffo, R. J., and Hohn, D. C. Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver. Ann. Intern. Med., 100: 736-743, 1984.
9. Meta-Analysis Group In Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J. Natl. Cancer Inst., 88: 252-258, 1996.
10. Lane, D. P., Midgley, C. A., Hupp, T. R., Lu, X., Vojtesek, B., and Picksley, S. M. On the regulation of the p53 tumour suppressor, and its role in the cellular response to DNA damage. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 347: 83-87, 1995.
11. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
12. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
13. Chen, P-L., Chen, Y., Bookstein, R., and Lee, W-H. Genetic mechanisms of tumor suppression by the human p53 gene. Science (Washington DC), 250: 1576-1580, 1990.
14. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., and Costa, J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA, 89: 4495-4499, 1992.
15. Fujiwara, T., Grimm, E. A., Mukhopadhyay, T., Zhang, W-W., Owen-Schaub, L. B., and Roth, J. A. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of wild-type p53 gene. Cancer Res., 54: 2287-2291, 1994.
16. Dameron, K. M., Volpert, O. V., Tainsky, M. A., and Bouck, N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin. Science (Washington DC), 265: 1582-1584, 1994.
17. Harris, M. P., Sutjipto, S., Wills, K. N., Hancock, W., Cornell, D., Johnson, D. E., Gregory, R. J., Shepard, H. M., and Maneval, D. C. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein. Cancer Gene Ther., 3: 121-130, 1996.
18. Wills, K. N., Maneval, D. C., Menzel, P., Harris, M. P., Sutjipto, S., Vaillancourt, M-T., Huang, W-M., Johnson, D. E., Anderson, S. C., Wen, S-F., Bookstein, R., Shepard, H. M., and Gregory, R. J. Development and characterization of recombinant adenoviruses encoding p53 for gene therapy of cancer. Hum. Gene Ther., 5: 1079-1088, 1994.
19. Clayman, G. L., El-Naggar, A. K., Roth, J. A., Zhang, W-W., Goepfert, H., Taylor, D. L., and Liu, T-J. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res., 55: 1-6, 1995.
20. Nielsen, L. L., Del, J., Maxwell, E., Armstrong, L., Maneval, D., and Catino, J. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts. Cancer Gene Ther., 4: 129-138, 1997.
21. Kock, H., Harris, M. P., Anderson, S. C., Machemer, T., Hancock, W., Sutjipto, S., Wills, K. N., Gregory, R. J., Shepard, H. M., Westphal, M., and Maneval, D. C. Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo. Int. J. Cancer, 67: 808-815, 1996.
22. Eastham, J. A., Hall, S. J., Sehgal, I., Wang, J., Timme, T. L., Yang, G., Connell-Crowley, L., Elledge, S. J., Zhang, W-W., Harper, J. W., and Thompson, T. C. In vivo gene therapy with p53 or p21 adenovirus for prostate cancer. Cancer Res., 55: 5151-5155, 1995.
23. Li, Q., Kay, M. A., Finegold, M., Stratford-Perricaudet, L. D., and Woo, S. L. C. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther., 4: 403-409, 1993.
24. Bookstein, R., Demers, W., Gregory, R., Maneval, D., Park, J., and Wills, K. p53 Gene therapy in vivo of hepatocellular, and liver metastatic colorectal cancer. Semin. Oncol., 23: 66-77, 1996.
25. Morris, H. P., and Meranze, D. R. Induction and some characteristics of "minimum deviation" and transplantable rat hepatomas. Recent Results in Cancer Res., 44: 103-114, 1974.
26. Zakut-Houri, R., Bienz-Tadmor, B., Givol, D., and Oren, M. Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells. EMBO., 4: 1251-1255, 1985.
27. Soussi, T. Nucleotide sequence of a cDNA encoding the rat p53 nuclear oncoprotein. Nucleic Acids Res., 16: 11384, 1988.
28. Wills, K. N., Huang, W-M., Harris, M. P., Machemer, T., Maneval, D. C., and Gregory, R. J. Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene. Cancer Gene Ther., 2: 191-197, 1995.
29. Huyghe, B. G., Liu, X., Sutjipto, S., Sugarman, B. J., Horn, M. T., Shepard, H. M., Scandella, C. J., and Shabram, P. Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography. Human Gene Ther., 6: 1403-1416, 1995.
30. Lafreniere, R., and Rosenberg, S. A. A novel approach to the generation and identification of experimental hepatic metastases in a murine model. J. Natl. Cancer Inst., 76: 309-322, 1986.
31. Sutanto-Ward, E., Sigurdson, E. R., Tremiterra, S., Lincer, R., Chapman, D., and Niedzwiecki, D. Adjuvant chemotherapy for colorectal hepatic metastases: role of route of administration and timing. Surg. Oncol., 1: 87-95, 1992.
32. Than, T. T., Sitzmann, J. V., Li, S-S., Lin, P-W., and Grochow, L. B. A method for hepatic arterial perfusion studies in the rat. J. Surg. Res., 47: 251-254, 1989.
33. Bass, C., Cabrera, G., Elgavish, A., Robert, B., Siegal, G. P., Anderson, S. C., Maneval, D. C., and Curiel, D. T. Recombinant adenovirus-mediated gene transfer to genitourinary epithelium in vitro and in vivo. Cancer Gene Ther., 2: 97-104, 1995.
34. Roemer, K., and Friedmann, T. Mechanisms of action of the p53 tumor suppressor and prospects for cancer gene therapy by reconstitution of p53 function. Ann. NY Acad. Sci., 716: 265-282, 1994.
35. Katayose, D., Gudas, J., Nguyen, H., Srivastava, S., Cowan, K. H., and Seth, P. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells. Clin. Cancer Res., 1: 889-897, 1995.
36. Roth, J. A., Nguyen, D., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Ferson, D. Z., Hong, W. K., Komaki, R., Lee, J. J., Nesbitt, J. C., Pisters, K. M. W., Putnam, J. B., Schea, R., Shin, D. M., Walsh, G. L., Dolormente, M. M., Han, C-I., Martin, F. D., Yen, N., Xu, K., Stephens, L. C., McDonne., T. J., Mukhopadhyay, T., and Cai, D. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat. Med., 2: 985-991, 1996.
37. Lesoon-Wood, L. A., Kim, W. H., Kleinman, H. K., Weintraub, B. D., and Mixson, A. J. Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice. Hum. Gene Ther., 6: 395-405, 1995.
38. Roth, J. A. Modification of tumor suppressor gene expression and induction of apoptosis in non-small cell lung cancer (NSCLC) with an adenovirus vector expressing wildtype p53 and cicplatin. Hum. Gene Ther., 7: 1013-1030, 1996.
39. Ackerman, N. B. The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery (St. Louis), 75: 589-596, 1974.
40. Lien, W. M., and Ackerman, N. B. The blood supply of experimental liver metastases II. A microcirculatory study of the normal and tumor vessels of the liver with the use of perfused silicone rubber. Surgery (St. Louis), 68: 334-340, 1970.
41. Bao, J., Zhang, W., and Kuno, M. T. Adenoviral delivery of recombinant DNA into transgenic mice bearing hepatocellular carcinomas. Hum. Gene Ther., 7: 355-365, 1996.
42. Roos, G., Christensson, P-I., Hag, I. A. E., Jakobsson, B., Teder, H., and Stenram. U. Degradable starch microspheres in cytostatic treatment of a liver carcinoma; experimental studies in rats with 5-fluorouracil, tauromustine, carmustine, doxorubibin and RSU-1069. Anticancer Res., 13: 635-642, 1993.
43. Civalleri, D., Scopinaro, G., Balletto, N., Claudiani, F., DeCian, F., Camerini, G., DePaoli, M., and Bonalumi, U. Changes in vascularity of liver tumors after hepatic arterial embolization with degradable starch microspheres. Br. J. Surg., 76: 699-703, 1989.
44. Takats, P. G. D., Kerr, D. J., Poole, C. J., Warren, H. W., and McArdle, C. S. Hepatic arterial chemotherapy for metastatic colorectal carcinoma. Br. J. Cancer, 69: 372-378, 1994.
45. Caruso, M., Panis, Y., Gagandeep, S., Houssin, D., Salzmann, J-L., and Klatzmann, D. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc. Natl. Acad. Sci. USA, 90: 7024-7028, 1993.
46. Chen, S-H., LiChen, X. H., Wang, Y., Kosai, K-I., Finegold, M. J., Rich, S. S., and Woo, S. L. C. Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc. Natl. Acad. Sci. USA, 92: 2577-2581, 1995.
47. Culver, K. W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E. H., and Blaese, R. M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (Washington DC), 256: 1550-1552, 1992.
48. Qian, C., Idoate, M., Bilbao, R., Sangro, B., Bruna, O., Vazquez, J., and Prieto, J. Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinoma. Hum. Gene Ther., 8: 349-358, 1997.
49. Brand, K., Arnold, W., Bartels, T., Lieber, A., Kay, M. A., Strauss, M., and Dorken, B. Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors. Cancer Gene Ther., 4: 9-16, 1997.
50. Drazan, K. E., Shen, X. D., Csete, M. E., Zhang, W. W., Roth, J. A., Busuttil, R. W., and Shaked, A. In vivo adenoviral-mediated human p53 tumor suppressor gene transfer and expression in rat liver after resection. Surgery (St. Louis), 116: 197-204, 1994.
51. Yang, Y. P., and Wilson, J. M. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4(+) CTLs in vivo. J. Immunol., 155: 2564-2570, 1995.
52. Trapnell, B. C. Adenoviral vectors for gene transfer. Adv. Drug Delivery Syst., 12: 185-199, 1993.
53. Engelhardt, J. F., Ye, X., Doranz, B., and Wilson, J. M. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA, 91: 6196-6200, 1994.
54. Jooss, K., Yang, Y., and Wilson, J. M. Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung. Hum. Gene Ther., 7: 1555-1566, 1996.
55. Vilquin, J., Guerette, B., Kinoshita, I., Roy, B., Goulet, M., Gravel, C., Roy, R., and Tremblay, J. FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Hum. Gene Ther., 6: 1391-1401, 1995.